REQUEST A DEMO
Total
USD $0.00
Search more companies

Median Diagnostics Inc. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Median Diagnostics Inc. Profile Updated: August 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Median Diagnostics Inc. is an enterprise based in South Korea. Its main office is in Chuncheon. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was established on August 28, 1999. Median Diagnostics Inc. currently employs 69 (2025) people. There was a net sales revenue drop of 1.85% reported in Median Diagnostics Inc.’s latest financial highlights for 2025. Over the same period, its total assets grew by 6.34%. In 2025, Median Diagnostics Inc.’s net profit margin increased by 9.96%.

Headquarters
878, Sunhwan-Daero, Dongnae-Myeon, Chuncheon-Si, Gangwon-Do, Korea
Chuncheon; Gangwon;

Contact Details: Purchase the Median Diagnostics Inc. report to view the information.

Website: http://www.mediandiagnostics.com

Basic Information
Total Employees:
Purchase the Median Diagnostics Inc. report to view the information.
Outstanding Shares:
Purchase the Median Diagnostics Inc. report to view the information.
Financial Auditors:
Purchase the Median Diagnostics Inc. report to view the information.
Incorporation Date:
August 28, 1999
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
Median Biotech Inc
100%
Company Performance
Financial values in the chart are available after Median Diagnostics Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-1.85%
Total Operating Revenue
1.3%
Operating Profit
524.31%
EBITDA
194.22%
Net Profit/Loss for the Period
97.38%
Total Assets
6.34%
Total Equity
11.24%
Operating Profit Margin
17.03%
Net Profit Margin
9.96%
Return on Equity (ROE)
4.58%
Debt / Equity
-3.6%
Quick Ratio
6.86%
Cash Ratio
-0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?